tiprankstipranks

James Tobin Insider Profile

4 Followers
James Tobin, Director at Curis, holds 144.92K shares in Curis (Ticker: CRIS), holds 0.00 shares in Chiasma (Ticker: CHMA), holds 194.34K shares in TransMedics Group (Ticker: TMDX).
tipranks
James Tobin

James Tobin
Curis (CRIS)
Director

Ranked #75,917 out of 98,909 Corporate Insiders

Profitable Transactions

57%
4 out of 7 Profitable Transactions

Average Return

-14.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$71M
59.72%
37.86%
2.41%
0.00%
0.00% Others
A breakdown of James Tobin's holdings

Insider Roles

Boston Scientific
(BSX)
President & CEO, Director
TransMedics Group
(TMDX)
Director
Curis
(CRIS)
Director
Lyra Therapeutics
(LYRA)
Director
+1 other positions
Roles that James Tobin holds in companies

Most Profitable Insider Trade

Stock:
Globus Medical
(GMED)
Rating:Informative Sell
Date:Mar 17, 2022 - Mar 17, 2023
Return:+25.20%
The most profitable trade made by James Tobin

James Tobin's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Curis
May 07, 2013
Director
Uninformative Sell
151.84K
$1.71M
CHMA
Chiasma
$0.00
OXFD
Oxford Immunotec
Mar 12, 2021
Uninformative Sell
89.78K
$0.00
CVRS
Corindus Vascular Robotics
Oct 31, 2019
Uninformative Sell
454.16K
$0.00
TransMedics Group
May 07, 2024
Director
Uninformative Sell
1.50M
$26.81M
Lyra Therapeutics
Director
Globus Medical
Mar 17, 2022
Director
Informative Sell
579.41K
$0.00
Boston Scientific
President & CEO, Director
$42.29M
List of latest transactions for each holding click on a transaction to see James Tobin's performance on stock

James Tobin insider profile FAQ

What is the percentage of profitable transactions made by James Tobin?
The percentage of profitable transactions made by James Tobin is 57%.
    What is the average return per transaction made by James Tobin?
    The average return per transaction made by James Tobin is -14.50%.
      What stocks does James Tobin hold?
      James Tobin holds: CRIS, CHMA, OXFD, CVRS, TMDX, LYRA, GMED, BSX stocks.
        What was James Tobin’s latest transaction?
        James Tobin latest transaction was an Uninformative Sell of $151.84K.
          What was James Tobin's most profitable transaction?
          James Tobin’s most profitable transaction was an Informative Sell of GMED stock on March 17, 2022. The return on the trade was 25.20%.
            What is James Tobin's role in Curis?
            James Tobin's role in Curis is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.